Discontinuation report PRIMAXIN 500

Last updated on 2022-07-01 History
Report ID 149907
Drug Identification Number 00717282
Brand name PRIMAXIN 500
Common or Proper name imipenem and cilastatin sodium for injection
Company Name MERCK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CILASTATIN IMIPENEM
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500MG X 25 VIAL 20ML
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-07-02
Actual discontinuation date 2022-06-30
Remaining supply date 2022-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-07-01 English Compare
v10 2022-06-30 French Compare
v9 2022-06-30 English Compare
v8 2022-04-05 French Compare
v7 2022-04-05 English Compare
v6 2022-03-29 French Compare
v5 2022-03-29 English Compare
v4 2022-02-24 French Compare
v3 2022-02-24 English Compare
v2 2021-11-25 French Compare
v1 2021-11-25 English Compare

Showing 1 to 11 of 11